In other types of cancer, such as early breast carcinoma or gastric adenocarcinoma, high CX3CL1 expression (IHC) is correlated with increased stromal CD8, DC and NK cells and also associated with a disease-free survival benefit for both types of cancer and an overall survival improvement in breast carcinoma [131,132]. This evidence concerns the gene CX3CL1 and breast carcinoma.